Eva Bondesson

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi request reprint In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol
    Eva Bondesson
    Department of Clinical Physiology, Lund University, Malmo University Hospital, S 205 02, Malmo, Sweden
    Int J Pharm 232:149-56. 2002
  2. ncbi request reprint Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol deposition
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Int J Pharm 251:33-47. 2003
  3. ncbi request reprint Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol deposition
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Int J Pharm 258:227-40. 2003
  4. ncbi request reprint Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs
    Eva Bondesson
    AstraZeneca R and D Lund, Sweden
    J Aerosol Med 18:23-33. 2005
  5. ncbi request reprint Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Pharm Res 23:2122-8. 2006
  6. pmc Site of deposition and absorption of an inhaled hydrophilic solute
    Eva Bondesson
    AstraZeneca R and D Lund, SE 22187 Lund, Sweden
    Br J Clin Pharmacol 63:722-31. 2007
  7. ncbi request reprint Exhaled breath condensate-site and mechanisms of formation
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87 Lund, Sweden
    J Breath Res 3:016005. 2009

Detail Information

Publications7

  1. ncbi request reprint In vitro and in vivo aspects of quantifying intrapulmonary deposition of a dry powder radioaerosol
    Eva Bondesson
    Department of Clinical Physiology, Lund University, Malmo University Hospital, S 205 02, Malmo, Sweden
    Int J Pharm 232:149-56. 2002
    ....
  2. ncbi request reprint Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol deposition
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Int J Pharm 251:33-47. 2003
    ....
  3. ncbi request reprint Planar gamma scintigraphy--points to consider when quantifying pulmonary dry powder aerosol deposition
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Int J Pharm 258:227-40. 2003
    ....
  4. ncbi request reprint Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs
    Eva Bondesson
    AstraZeneca R and D Lund, Sweden
    J Aerosol Med 18:23-33. 2005
    ..By computational modeling of the aerosol transport and deposition, that finding was mechanistically explained by differences in airway caliber as a consequence of the level of lung inflation at the time-point of dose delivery...
  5. ncbi request reprint Effects of sodium taurocholate on the absorption of inhaled 99mTc-DTPA
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87, Lund, Sweden
    Pharm Res 23:2122-8. 2006
    ....
  6. pmc Site of deposition and absorption of an inhaled hydrophilic solute
    Eva Bondesson
    AstraZeneca R and D Lund, SE 22187 Lund, Sweden
    Br J Clin Pharmacol 63:722-31. 2007
    ..To characterize the absorption kinetics and bioavailability of an inhaled hydrophilic solute deposited at various sites within the airways...
  7. ncbi request reprint Exhaled breath condensate-site and mechanisms of formation
    Eva Bondesson
    AstraZeneca R and D Lund, SE 221 87 Lund, Sweden
    J Breath Res 3:016005. 2009
    ....